Articles > Healthcare & Insurance
As the novel coronavirus COVID-19 continues to spread in the United States, many people are understandably concerned about access to their medications. Health officials and medical professionals working in federal, state and local governments recommend that high-risk individuals with underlying health conditions such as Type 1 Diabetes, stock up on their prescription medications, in addition to practicing basic hygiene and avoiding crowded places.
Last month, the FDA approved the Tandem Diabetes Care update to its t:slim X2 insulin pump Control-IQ technology, clearing the way for the first automated and interoperable insulin dosing system on the U.S. market.
Qualifying plans which offer the option of health savings accounts can provide pre-deductible coverage for some care for chronic conditions like diabetes, according to a new rule issued by the U.S. Treasury Department.
A profile of Dr. Michael Heile of The Family Medical Group-Cincinnati.
The groundbreaking legislation does not put a similar limit on insulin costs for those who lack insurance, however.
If the Fifth Circuit Court of Appeals agrees, this could put the health care coverage for many people with type 1 diabetes at risk.
Pediatric endocrinologist Sarah D. Corathers works with a special group of colleagues to tailor diabetes management to individual needs.
The pharmacy chain admits to dispensing pens in packs of five, even when the prescribed amount called for less, and then billed the programs for the extra amount.
Five questions with a diabetes health data geek about how data might be harnessed to improve diabetes care now and in the future.
Dr. Sanjeev N. Mehta, a Joslin Diabetes Center pediatric endocrinologist, sees opportunity in standardizing patient data collection. He’s collaborating with the T1D Exchange Quality Improvement Collaborative to harness clinical data to improve diabetes care.
